Virginia - Session 2026
Title: Office-based buprenorphine treatment; Board of Medicine to amend regulations.
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care.
| Date | Event | Detail |
|---|---|---|
| 2026-01-13 | Introduced | Bill introduced |
| 2026-04-06 | Status | enacted |
| 2026-04-06 | Latest Action | Acts of Assembly Chapter text (CHAP0207) |